For the best experience on the Abcam website please upgrade to a modern browser such as Google Chrome
Listen in as Dr David Rubinsztein of the Cambridge Institute for Medical Research, at the University of Cambridge, discusses how certain neurodegenerative diseases are associated with compromised autophagy.
David Rubinsztein completed his BSc(Med) Hons and PhD at the University of Cape Town after his basic medical training and housejobs. He came to Cambridge in 1993 as a senior registrar in Genetic Pathology.
David is currently deputy director of the Cambridge Institute for Medical Research and Academic Lead of the Alzheimer’s Research UK Cambridge Drug Discovery Institute.
David has published more than 350 papers, which have an h index of 107 and >50,000 citations (Google Scholar). He was selected as a Thomson Reuters’ Highly Cited Researcher. He has also been elected as a Fellow of the Academy of Medical Sciences (2004), Professor of Molecular Neurogenetics (University of Cambridge, personal chair (2005)), as an EMBO member (2011) and as a Fellow of the Royal Society (2017). David was awarded the Graham Bull Prize for Clinical Science (Royal College of Physicians, 2007) and the 2017 Thudichum Medal (Biochemical Society) for outstanding contributions to neuroscience.